The inactivation of this transcriptional regulator led to decreased infiltration of T cells even in a mouse model, as the authors applied NOD-scid IL2Rgammanull (NSG) mouse to establish tumor of control or NSD1 shRNA and human peripheral blood mononuclear cell (PBMC) injection. This evidence concerns the gene NSD1 and neoplasm.